ERBB2 c.311G>A ;(p.G104D)

Variant ID: 17-37864659-G-A

NM_004448.2(ERBB2):c.311G>A;(p.G104D)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


The prognostic effects of somatic mutations in ER-positive breast cancer.

Nature Communications
Griffith, Obi L OL; Spies, Nicholas C NC; Anurag, Meenakshi M; Griffith, Malachi M; Luo, Jingqin J; Tu, Dongsheng D; Yeo, Belinda B; Kunisaki, Jason J; Miller, Christopher A CA; Krysiak, Kilannin K; Hundal, Jasreet J; Ainscough, Benjamin J BJ; Skidmore, Zachary L ZL; Campbell, Katie K; Kumar, Runjun R; Fronick, Catrina C; Cook, Lisa L; Snider, Jacqueline E JE; Davies, Sherri S; Kavuri, Shyam M SM; Chang, Eric C EC; Magrini, Vincent V; Larson, David E DE; Fulton, Robert S RS; Liu, Shuzhen S; Leung, Samuel S; Voduc, David D; Bose, Ron R; Dowsett, Mitch M; Wilson, Richard K RK; Nielsen, Torsten O TO; Mardis, Elaine R ER; Ellis, Matthew J MJ
Publication Date: 2018-09-04

Variant appearance in text: ERBB2: G104D
PubMed Link: 30181556
Variant Present in the following documents:
  • 41467_2018_5914_MOESM6_ESM.xlsx, sheet 10
  • 41467_2018_5914_MOESM6_ESM.xlsx, sheet 9
  • 41467_2018_5914_MOESM6_ESM.xlsx, sheet 1
  • 41467_2018_5914_MOESM6_ESM.xlsx, sheet 2
  • 41467_2018_Article_5914.pdf
  • 41467_2018_5914_MOESM6_ESM.xlsx, sheet 12
View BVdb publication page



Epitope-specific affinity maturation improved stability of potent protease inhibitory antibodies.

Biotechnology And Bioengineering
Lopez, Tyler T; Chuan, Chen C; Ramirez, Aaron A; Chen, Kuan-Hui E KE; Lorenson, Mary Y MY; Benitez, Chris C; Mustafa, Zahid Z; Pham, Henry H; Sanchez, Ramon R; Walker, Ameae M AM; Ge, Xin X
Publication Date: 2018-11

Variant appearance in text: HER2: G104D
PubMed Link: 30102763
Variant Present in the following documents:
  • Main text
View BVdb publication page